Exciton Lands Distribution Agreement for US Veteran Health Facilities

EDMONTON, June 29, 2011 /PRNewswire/ - Exciton Technologies Inc. today announced the Company has signed a distribution agreement with Marathon Medical, adding them to the existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs on behalf of the U.S. General Services Administration (GSA), effective July 1^st.

"We are excited about partnering with Marathon Medical to reach this important milestone in our commercialization efforts" says Rod Precht, President and Founder, Exciton Technologies Inc.  "Since receiving approval to market the exsalt™ SD7 Wound Dressing in the US and Canada, it has been our goal to secure a place on formularies of hospitals. A listing on the FSS offers access to this effective wound care product at the lowest available price."

"Adding Exciton to our supply schedule just made sense," says John St. Leger, President, Marathon Medical.   "What is unique about Exciton's product is the superior attributes over other leading silver technologies. At Marathon Medical, we combine excellent products with competitive pricing to bring the greatest value to the veteran patient."

The arrangement allows Exciton to expand the availability of its exsalt™ SD7 Wound Dressing throughout the entire federal healthcare system, the largest healthcare provider in the United States with over 1,300 Veterans health facilities, Department of Defense, Military Hospitals, and other government agencies.

A recent resurgence in the use of silver dressings has been largely due to an increase in the number of antimicrobial-resistant organisms. With a long history of safety, silver continues to be the most promising antimicrobial treatment in the market. Initial evaluations of the exsalt™ SD7 Wound Dressing within the US over the last year are validating the performance of this next generation product within a rapidly growing market.

About exsalt™ SD7 Wound Dressing
The exsalt™ SD7 Wound Dressing is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second degree burns, grafts and donor sites, and other acute or chronic wounds.  The exsalt™ SD7 Wound Dressing maintains its broad spectrum antimicrobial activity for up to seven days.

SOURCE Exciton Technologies Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED